U.S. stocks bounced back from their worst week in nearly two months Monday as optimism about a potential vaccine for the coronavirus and hopes for an economic recovery in the second half of the year put investors in a buying mood.
The S&P 500 was up 3.5 per cent, on track for its best day since early April. The gains erased all of its losses from last week, when the index posted its worst showing since late March and its third weekly loss in the last four.
Toronto’s stock exchange was closed for the Victoria Day holiday.
But it wasn’t just U.S. stocks moving higher. Bond yields rose broadly in another sign of positive sentiment among investors.
Stocks were already headed for a higher opening on Wall Street when a drug company announced encouraging results in very early testing of an experimental coronavirus remedy. The stock of the company, Massachusetts-based Moderna, jumped 21.1 per cent.
Investors were also encouraged by remarks over the weekend from Federal Reserve Chair Jerome Powell, who expressed optimism that the U.S. economy could begin to recover in the second half of the year. Once the outbreak has been contained, he said, the economy should be able to rebound “substantially.”
The Dow Jones Industrial Average gained 963 points, or 4.1 per cent to 24,649. The Nasdaq composite climbed 2.7 per cent. Small-company stocks fared better than the rest of the market. The Russell 2000 index rose 5.8 per cent.
Investors are hoping that a working vaccine for COVID-19 can be developed, because it could provide the reassurance people and businesses need to ensure the reopening of the economy succeeds.
“The question of how quickly people come back, or will they come back to the way they used to do things, that’s much different if you have a vaccine,” said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors.
Cautious optimism
Traders are also encouraged that, so far at least, there hasn’t been a lot of data implying the reopening of the economy is going to lead to a resurgence in the number of COVID-19 cases, said Sam Stovall, chief investment strategist at CFRA.
“Of course, because we are responding to impressions, we could end up giving back some of these gains should additional information contest our beliefs,” he said.
Technology and financial stocks accounted for a big slice of the broad gains, along with health care and industrial companies. Energy stocks rose as the price of U.S. crude oil headed sharply higher, crossing above $30 a barrel for the first time in two months as oil production cuts kick in at the same time that demand is rising as the U.S. and other countries ease some of the restrictions aimed at stemming the spread of the outbreak.
Benchmark U.S. crude oil for June delivery jumped 8.1 per cent to settle at $31.82 a barrel. July Brent crude oil, the international standard, vaulted 7.1 per cent to $34.81 a barrel.
Bonds yields rose, another sign that pessimism was diminishing. The yield on the 10-year Treasury note, a benchmark for interest rates on many consumer loans, rose to 0.73 per cent from 0.64 per cent late Friday.
Fears of a crushing recession due to the coronavirus sent the S&P 500 into a skid of more than 30 per cent from its high in February. Hopes for a relatively quick rebound and unprecedented moves by the Federal Reserve and Congress to stem the economic pain fueled a historic rebound for stocks in April.
May got off to a downbeat start as investors balance cautious optimism of a recovery as economies around the world slowly open up again against worries that the moves could lead to another surge in coronavirus infections and more economic uncertainty. But Monday’s strong start to the week reversed all of the market’s losses so far this month.
“We had a near 30 per cent advance from the March 23 low to April 17, and then basically treaded water for a month as investors were expecting some sort of a retest of the prior low, which obviously did not come,” Stovall said. “Usually, markets need to catch their breath after a sprint higher.”
Wall Street is hoping that the reopening of businesses and the relaxation of stay-at-home mandates continue without any major setbacks, paving the way for corporate profits to bounce back.
Europe has been taking steps to reopen its economy more widely, and so far, new infections and deaths have slowed considerably across the continent. Some countries there started easing lockdowns a month ago and even the harshest shutdowns — such as those in Italy and Spain — have loosened significantly.
In his interview with CBS’s “60 Minutes,” Powell said the U.S. economy was fundamentally healthy before the virus forced widespread business shutdowns and tens of millions of layoffs. He noted that a full recovery won’t likely be possible before the arrival of a vaccine.
Before trading opened, Moderna said its experimental vaccine showed encouraging results in early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers. The vaccine generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers who were given either a low or medium dose.
Worldwide, about a dozen vaccine candidates are in the first stages of testing or nearing it. Health officials have said that if all goes well, studies of a potential vaccine might wrap up by very late this year or early next year.
Markets in Europe also notched strong gains Monday. The FTSE 100 in London rose 4.3 per cent and the DAX in Frankfurt climbed 5.7 per cent. France’s CAC 40 rose 5.2 per cent. Markets in Asia finished broadly higher.
www.cbc.ca 2020-05-18 20:14:19